Colorectal cancer (CRC) is the third most common cause of cancer death in the USA. Germline mutations in the apc tumor suppressor gene, one of the key players in the development of CRC and an important component in the Wnt/beta-catenin signaling pathway, are responsible for familial adenomatous polyposis (FAP). Mutations that result in constitutive activation of the Wnt/-catenin signaling pathway can lead to colon cancer. Wnt(s) have diverse roles in regulating cell fate, proliferation, migration, and death. beta-Catenin is highly expressed in many cancer cell types and promotes growth and tumor formation. Elevated beta-catenin activity in carcinogenesis model systems and neoplastic tissues suggests that this enzyme is a valid target for chemoprevention. By using computational biology with BlueGene/L and GPU supercomputers, we have identified/synthesized several small molecule inhibitors of beta-catenin that are highly effective or have good potential to suppress colon carcinogenesis. In this application, we propose to use state of the art technologies to continue to identify, characterize, test and validate novel, nontoxic small molecule inhibitors of beta-catenin. Our approaches include determination of binding, binding affinities, identification of the specific binding sites, and examining the resulting structural changes by computational simulation using our supercomputer systems. We will validate the effectiveness of these inhibitors by performing protein binding assays, cell transformation assays and in vivo animal experiments, including xenograft models and the AOM-induced colon cancer and APCMin mouse models. Through these studies, we will develop more effective agents targeting beta-catenin with fewer side effects for the chemoprevention of colon cancer.
Colorectal cancer is the third most common cause of cancer death in the USA. Deregulation of the apc tumor suppressor gene, one of the key players in the development of colorectal cancer and an important component in the Wnt/beta-catenin signaling pathway, is responsible for familial adenomatous polyposis. By using our BlueGene/L and GPU supercomputers, we have identified several potential small molecule inhibitors of -catenin that are effective or show good potential to suppress colon cancer cell growth. We propose to identify and test these and additional novel, nontoxic small molecule chemopreventive agents targeting beta-catenin in cell and mouse models.
|Wang, Li; Wang, Xiangyu; Chen, Hanyong et al. (2018) Gossypin inhibits gastric cancer growth by direct targeting of AURKA and RSK2. Phytother Res :|
|Yao, Ke; Lee, Sung-Young; Peng, Cong et al. (2018) RSK2 is required for TRAF6 phosphorylation-mediated colon inflammation. Oncogene 37:3501-3513|
|Shi, Yuanyuan; Liu, Xuejiao; Fredimoses, Mangaladoss et al. (2018) FGFR2 regulation by picrasidine Q inhibits the cell growth and induces apoptosis in esophageal squamous cell carcinoma. J Cell Biochem 119:2231-2239|
|Zhang, Tianshun; Wang, Qiushi; Fredimoses, Mangaladoss et al. (2018) The Ashitaba (Angelica keiskei) Chalcones 4-hydroxyderricin and Xanthoangelol Suppress Melanomagenesis By Targeting BRAF and PI3K. Cancer Prev Res (Phila) 11:607-620|
|Wang, Qiushi; Gao, Ge; Zhang, Tianshun et al. (2018) TRAF1 Is Critical for Regulating the BRAF/MEK/ERK Pathway in Non-Small Cell Lung Carcinogenesis. Cancer Res 78:3982-3994|
|Song, Mengqiu; Liu, Xuejiao; Liu, Kangdong et al. (2018) Targeting AKT with Oridonin Inhibits Growth of Esophageal Squamous Cell Carcinoma In Vitro and Patient-Derived Xenografts In Vivo. Mol Cancer Ther 17:1540-1553|
|Zykova, Tatyana; Zhu, Feng; Wang, Lei et al. (2018) Targeting PRPK Function Blocks Colon Cancer Metastasis. Mol Cancer Ther 17:1101-1113|
|Roh, Eunmiri; Lee, Mee-Hyun; Zykova, Tatyana A et al. (2018) Targeting PRPK and TOPK for skin cancer prevention and therapy. Oncogene 37:5633-5647|
|Jin, Guoguo; Yao, Ke; Guo, Zhiping et al. (2017) APIO-EE-9 is a novel Aurora A and B antagonist that suppresses esophageal cancer growth in a PDX mouse model. Oncotarget 8:53387-53404|
|Yamamoto, Hiroyuki; Ryu, Joohyun; Min, Eli et al. (2017) TRAF1 Is Critical for DMBA/Solar UVR-Induced Skin Carcinogenesis. J Invest Dermatol 137:1322-1332|
Showing the most recent 10 out of 20 publications